Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea
· Delayed Price · Currency is KRW
24,750
+100 (0.41%)
Aug 14, 2025, 3:30 PM KST
Onconic Therapeutics Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | 4,572 | -8,093 | 1,682 | -14,432 | -15,149 |
| Depreciation & Amortization | 473.54 | 452.67 | 460.13 | 199.66 | 181.88 |
| Other Amortization | - | - | - | 1.18 | 1.08 |
| Loss (Gain) From Sale of Assets | - | - | 0.7 | - | - |
| Stock-Based Compensation | 918.27 | 1,026 | 578.03 | 472.48 | 163.17 |
| Other Operating Activities | -3,413 | 4,427 | -774.88 | -277.64 | 6,829 |
| Change in Accounts Receivable | -7,949 | -7,222 | 104.5 | -99 | -5.5 |
| Change in Accounts Payable | 2,234 | 708.67 | - | - | - |
| Change in Income Taxes | 463.39 | 463.39 | - | - | - |
| Change in Other Net Operating Assets | -1,280 | 396.57 | 2,089 | -825.75 | -879.32 |
| Operating Cash Flow | -3,981 | -7,841 | 4,140 | -14,961 | -8,859 |
| Capital Expenditures | -258.02 | -141.28 | -1,157 | -2,575 | -2.67 |
| Sale of Property, Plant & Equipment | - | - | 38 | - | - |
| Sale (Purchase) of Intangibles | - | - | - | - | -5.88 |
| Other Investing Activities | 65.65 | 70.42 | 108.76 | 135.75 | - |
| Investing Cash Flow | -192.37 | -70.85 | -1,011 | -2,439 | -8.55 |
| Long-Term Debt Repaid | - | -179.92 | -153.85 | -142.06 | -142.06 |
| Net Debt Issued (Repaid) | -191.22 | -179.92 | -153.85 | -142.06 | -142.06 |
| Issuance of Common Stock | 20,626 | 19,762 | - | - | 7,498 |
| Other Financing Activities | - | - | 114 | - | - |
| Financing Cash Flow | 20,435 | 19,582 | -39.85 | 25,858 | 27,356 |
| Foreign Exchange Rate Adjustments | 345.44 | 1,229 | -196.39 | - | - |
| Miscellaneous Cash Flow Adjustments | - | - | -108.76 | - | - |
| Net Cash Flow | 16,606 | 12,899 | 2,784 | 8,458 | 18,488 |
| Free Cash Flow | -4,239 | -7,982 | 2,983 | -17,536 | -8,861 |
| Free Cash Flow Margin | -14.41% | -53.79% | 14.16% | -18458.96% | -14769.11% |
| Free Cash Flow Per Share | - | -976.30 | 5160.40 | -30339.54 | -15475.92 |
| Cash Income Tax Paid | 646.5 | 912.06 | 2,170 | 2.18 | 2.71 |
| Levered Free Cash Flow | -6,258 | -50,062 | 16,304 | 13,630 | - |
| Unlevered Free Cash Flow | -6,248 | -49,646 | 17,413 | 14,304 | - |
| Change in Working Capital | -6,532 | -5,653 | 2,193 | -924.75 | -884.82 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.